Mysterious Fog in the US , Canada and UK: A dense, eerie fog with a "burning chemical-like smell" has spooked a good part of North America and parts of the United Kingdom and Canada. With social media amplifying all concerns, this phenomenon has sparked attention across all social media platforms. However, at the heart of this mysterious fog are a conjunction of natural events, social psychology, and environmental conditions that culminated in all the conspiracy theories and public health fears. Here's a closer look at the mysterious fog, its potential causes, and the societal response it has triggered.

Fog that Feeds Fear

The first reports of this "mysterious fog" came in from Florida where a resident said that they experienced respiratory symptoms, feverish warmth, and stomach cramps after contact with the fog. Similar stories started flooding social media, and within a day or two, a sinister force seemed to sweep across the United States, Canada, and parts of the UK. From Texas to Minnesota, people reported weird odors and health issues that they thought were linked to this bizarre atmospheric event.

Some witnesses were said to see "white particles" swirling through the air; theories ranged from a chemical attack or experimental weapon to drone-related chemical dispersals and references to historical military experiments, such as the infamous 1950s "Operation Sea-Spray."

Fuel to the fire were added when videos and posts, hundreds of thousands in number, began circulating on social media sites like TikTok and X (formerly Twitter) speculating on the origin of the fog. Hashtags like #ToxicFog went trending for days. Hysteria created a self-reinforcing loop in which every post spurred further scrutiny and fear.

Scientific Explanation of the Dense Mysterious Fog

1. What is Fog?

Fog is essentially a low-lying cloud formed when the air temperature cools to its dew point, causing water vapor to condense into tiny droplets or ice crystals. Several types of fog—advection fog, radiation fog, and valley fog—can form depending on conditions such as warm, moist air moving over cooler land or when temperatures plummet rapidly under clear skies.

2. Why the Chemical Smell?

Such chemical-like smell as reported during the occurrence of fog events is sometimes attributed to air pollution. It acts like a sponge, where it absorbs these pollutants, which include sulfur dioxide and nitrogen oxides, among others, that emit from industries. This mixture, therefore, leads to a stench that could be mistaken as unnatural or even toxic.

Also Read: Health Concerns Rise As US, Canada, and UK Come Under The Blanket Of Thick, Dense, Toxic Fog

3. What are the Health Concerns?

High moisture levels from fog can significantly exacerbate symptoms related to respiration, but especially in already predisposed asthmatics and allergy patients. The connection of these symptoms with actual fever, stomach cramps, and puffy eyes is too remote. Experts assume that the irritating effects of entrapped pollutants trapped in fog tend to affect more the eyes and throat rather than the rest of the body affected by some report.

Psychological Effects of Mass Panic Caused by Social Media

Social media amplified a natural weather event into a health epidemic. It made the personal experience of individuals become a cause for fear and speculation, a domino effect.

According to psychologists, this is a concept of selective perception, wherein once people's attention is drawn to environmental anomalies, they begin to notice them. This mirrors earlier panics, such as the Seattle windshield pitting panic of 1954. Then, atomic bomb testing caused fear in many and started to have people looking at their windshields for small marks that they had not seen before. Likewise, postings on the strangeness of the fog probably increased public awareness and suspicion, with people looking to attach unrelated symptoms to the phenomenon.

The fog hysteria shares a commonality with other instances of mass panic, such as the "drone sightings" of recent years or the Cold War-era fears of biological warfare.

Also Read: Mysterious Fog Is Making Americans Sick

These events underscore how fear can cloud judgment, especially when amplified by social media and sensationalist headlines. While historical cases, such as "Operation Sea-Spray," offer concrete evidence of the existence of unethical experiments, the jump from a natural weather condition to theories of chemical attacks exemplifies a more modern trend of connecting unrelated dots, all wonderfully seeded in distrust and anxiety.

Despite the swirling rumors, meteorologists and scientists are in agreement that the mysterious fog is not as alarming as it seems. It is well known that fog traps and amplifies pollutants, especially in urban and industrial regions. Moreover, winter months are the most conducive for fog formation, so its recent prevalence is unsurprising.

On the other hand, environmentalists advise that the fog should wake everyone up to increased levels of pollution. The reported odors and health irritations could be just symptoms of far deeper systemic issues like industrial emissions and lack of control over air quality.

The authorities must be transparent in their communication to combat misinformation and allay public fears. Governments and environmental agencies must provide timely updates on weather phenomena, air quality, and health risks. Initiatives like real-time pollutant tracking and public education campaigns can help demystify natural occurrences while addressing valid environmental concerns.

The mysterious Canada fog is a compelling case study in how environmental events intersect with psychology and societal dynamics. While rooted in natural phenomena, the fog became a vessel for collective fears, amplified by modern technology and historical anxieties.

In this information era where communication occurs at an almost lightning pace, the fog becomes a metaphor that reminds everyone about scientific literacy, environmental responsibility, and an effective balance when considering public concern. Whether perceived as a marvel of nature or as a tale that serves to teach, it left a very powerful mark in people's minds.

After Rajasthan and Hyderabad, Chhattisgarh today reported three suspected cases of Ebola involving foreign nationals.

According to media reports, the three have been isolated in Durg and placed under a 21-day quarantine as a precaution.

Chhattisgarh Health Minister Shyam Bihari Jaiswal announced that the state is fully prepared to handle any potential Ebola virus infection, stressing that hospitals and quarantine facilities have been put on alert and necessary arrangements are in place to ensure public safety.

Speaking to reporters, Jaiswal said the three individuals under observation were nationals from African countries and were being monitored in line with health protocols.

He added that no Ebola infection had been confirmed so far and that none of the individuals were showing symptoms of the disease.

"We have been fully prepared across the state at every level for a month now. The three individuals placed in isolation in Durg are nationals from African countries and have been quarantined for 21 days as a precautionary measure. So far, tests have not confirmed the presence of the virus, nor are they exhibiting any symptoms," he said.

Two Suspected Cases In Hyderabad

Earlier, two people in Hyderabad who returned from Sudan were isolated.

A Sudanese national, a student in his 20s, with a fever, was admitted to the state-run Gandhi Hospital. The student's condition improved, and he had no fever on Friday morning. His attendant was advised to stay in isolation at home, according to media reports.

Also read: WHO Says Ebola Fight Is Catching Up; Expert Explains Science Behind Patient Recoveries

Another Sudanese national, who arrived at Rajiv Gandhi International Airport a day earlier, was also shifted to the isolation ward of Gandhi Hospital for further tests after he was found to have a fever during thermal screening at the airport. The 35-year-old, who had come to Hyderabad for knee surgery, had no fever as of Friday morning and was asymptomatic, officials said.

Samples containing oral and nasal swabs have been collected and will be sent to the Centre for Cellular and Molecular Biology (CCMB) for testing. Test reports of both individuals are awaited.

Rajasthan Woman Isolated

Meanwhile, Rajasthan has also isolated one woman who returned from Uganda following symptoms.

During routine health screening at the airport, she exhibited symptoms associated with Ebola infection. The health department was immediately informed, and she was placed under special observation.

While she has displayed symptoms similar to Ebola infection, confirmation can only be made after laboratory testing. The results are awaited.

No Ebola Case Reported In India

Read More: Bundibugyo Ebola Outbreak: WHO Identifies Experimental Treatments, Vaccines

All suspected cases have been linked to travel to Ebola-affected countries such as Uganda, the Democratic Republic of Congo, and Sudan.

"No Ebola disease cases have been reported in India," the Health Ministry said in its latest update on June 3. The Health Ministry has also advised travelers arriving from Ebola-affected countries, including Uganda and the Democratic Republic of Congo, to remain alert for symptoms and seek medical guidance if they feel unwell.

"For information, guidance, and assistance, call MoHFW's 24x7 Health Helpline: 1075," the ministry said on X.

Ebola: A Global Health Emergency

On May 17, the World Health Organization classified the Ebola outbreaks in Uganda and the Democratic Republic of Congo as a Public Health Emergency of International Concern (PHEIC).

A total of 452 Ebola cases have been confirmed in the Democratic Republic of Congo, including 82 deaths. Uganda has reported 16 confirmed cases.

Meanwhile, the number of suspected cases has fallen from more than 1,000 last week to 116 as health teams work through the backlog. Six people in the DRC and two in Uganda have recovered to date.

After previously warning that Ebola was "outpacing us," WHO Director-General Tedros Adhanom Ghebreyesus said on Thursday that "we are catching up" as efforts to contain the outbreak in the Democratic Republic of Congo show progress.

A total of 452 Ebola cases have been confirmed in the Democratic Republic of Congo, including 82 deaths. Uganda has reported 16 confirmed cases. Meanwhile, the number of suspected cases has fallen from more than 1,000 last week to 116 as health teams work through the backlog.

WHO Sees Signs of Progress

“What I saw gave me hope,” Ghebreyesus said at a press conference.

“The outbreak had a big head start, and we're still behind, but under the leadership of the Government of DRC, we are catching up,” he added.

Importantly, he noted that six people in the DRC and two in Uganda have recovered to date, “showing that people can survive Ebola if they have access to care and go to health facilities as soon as they show symptoms.”

Why Are Patients Recovering?

The latest outbreak is caused by the Bundibugyo strain of the Ebola virus, for which there is currently neither a vaccine nor an antiviral treatment. So how are patients recovering?

Dr. Rajeev Jayadevan, Co-Chairman of the National IMA COVID Task Force and Past President of the Indian Medical Association, Cochin, told HealthandMe that a combination of factors—including the virus strain, access to medical care, and individual immune responses—can significantly influence whether a patient survives the disease.

Ebola virus disease is a severe illness caused by different strains of the Ebola virus. The current outbreak is linked to the Bundibugyo strain, which has a lower mortality rate than the more lethal Zaire strain responsible for several previous outbreaks, he said.

“The mortality of Ebola virus disease is tied to several components,” Dr. Rajeev explained.

Early Medical Care Improves Survival

One of the most important factors is access to early medical attention and supportive care. Patients who receive prompt treatment at well-equipped healthcare facilities staffed by experienced healthcare workers have a much greater chance of survival.

However, such healthcare access is often limited in outbreak-affected regions of Africa due to ongoing conflicts and socioeconomic challenges.

“The chance of survival is much higher if a person receives good medical attention and early supportive care,” he said.

Bundibugyo Strain vs Zaire Strain

Also read: Ebola Bundibugyo Strain: All You Should Know About The Rare Virus

The strain of the virus also plays a critical role. Dr. Rajeev said that because the Bundibugyo strain is less lethal than the Zaire strain, more infected individuals are expected to survive under similar conditions.

“If a hundred people get infected with the Zaire strain and another hundred with the Bundibugyo strain, more people in the Bundibugyo group will survive, all other conditions remaining the same,” he said.

Difference In Immune Response

Another important factor is the body's immune response, which varies from person to person. Dr. Rajeev highlighted the role of human leukocyte antigens (HLA), proteins that help the immune system recognize and respond to invading pathogens. Because each individual's HLA profile is unique, people infected with the same virus can generate different immune responses.

“HLA works closely with the immune system by presenting pieces of the virus to immune cells, helping the body build a targeted response,” he said.

Also read: Ebola Alert In India: Rajasthan, Hyderabad Report Suspected Cases of Deadly Virus

This biological diversity is one reason why the same infection can affect individuals differently. It is also considered an evolutionary safeguard that helps prevent a single pathogen from devastating the entire human population.

The Role of Probability

Dr. Rajeev also pointed to a simple statistical reality. “If the mortality rate in the current outbreak is around 30 per cent, that means about 70 per cent of infected individuals are expected to survive,” he said.

According to the expert, survival often results from a combination of favorable factors, including infection with a less lethal strain, timely medical care, a strong immune response, and the overall probability of recovery within a given outbreak.

The UK National Health Service (NHS) has approved the free rollout of a breakthrough ovarian cancer drug, benefiting hundreds of women with hard-to-treat cancer starting today.

Importantly, the US FDA-approved drug is the first new addition to NHS treatment for this group of patients in over 20 years.

The last major NHS treatment introduced for these patients was the rollout of liposomal doxorubicin and paclitaxel in the early 2000s.

The NHS, in a statement, said that the new targeted therapy, mirvetuximab soravtansine, will be offered to patients living with ovarian cancer whose disease has stopped responding to standard (platinum-based) chemotherapy, providing new hope of extra time to live.

Mirvetuximab soravtansine (Elahere) has been developed by AbbVie. The NHS estimates up to 400 patients in England each year could benefit.

“This represents the most significant breakthrough in NHS treatment for these hard-to-treat ovarian cancers in over two decades – and we’re delighted it will now offer hundreds of women much-needed hope of precious extra time with their loved ones,” said Professor Ruth Plummer, NHS national clinical lead for cancer drugs.

How Does The Drug Work?

According to the NHS, the drug combines a ‘homing’ antibody with a cancer-killing medicine, often described by scientists as a ‘biological missile’ or ‘Trojan horse’ therapy.

It works by attaching to ovarian cancer cells that have a protein called folate receptor alpha (FRα) on their surface, before releasing a cancer-killing molecule that destroys the cell from within.

In a major global clinical trial involving eight NHS hospitals, the treatment delayed cancer progression and prolonged survival, with patients living 16.5 months on average compared to 12.8 months with chemotherapy.

Also read: New Pancreatic Cancer Drug Daxaronrasib May Benefit Patients With Lung And Ovarian Tumors Too

Who Can Avail The Drug Through The NHS?

Following a recommendation by the National Institute for Health and Care Excellence (NICE), the treatment will be available for:

• patients with epithelial ovarian cancer,
• peritoneal or fallopian tube cancer that has become resistant to platinum-based chemotherapy
• whose tumors contain the FRα protein targeted by the drug.

The treatment is given intravenously (via a drip) over two to four hours, once every three weeks.

Are There Any Side Effects?

The NHS stated that the drug may also have more tolerable side effects than traditional chemotherapy, as it is aimed more precisely at cancer cells than chemotherapy, which can also harm healthy cells.

Common side effects include:

• Eye problems such as blurred vision or dry eyes
• Tiredness
• Nausea
• Low blood counts

Most side effects are manageable with monitoring and supportive care.

Read More: Alan Brazil Shares Survival Story After Heart Stopped During Liver Transplant

Ovarian Cancer Remains A Major Health Challenge

Ovarian cancer is one of the leading causes of death from gynecological cancer worldwide. In the UK, there are around 7,500 new diagnoses each year.

Standard treatment for ovarian cancer typically involves surgery and chemotherapy, but around 80 per cent of patients with advanced disease relapse, and most eventually develop resistance to chemotherapy.

More than a third of patients (37 per cent) treated with mirvetuximab soravtansine also saw their tumors shrink by at least 30 per cent, compared to 16 per cent of patients receiving chemotherapy in clinical trials.